Physician profile
Benjamin Steven Eike
NPI 1346737236
$7,299.79
in general payments reported to CMS, 2019-2025
12 companies · $322 in 2025
The $322 reported for 2025 was more than what 87% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,122 · 2023: $4,430 · 2024: $425 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,890 · Food and Beverage: $2,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,890.33 |
| Food and Beverage | $2,287.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,532.66 | 2023-2025 | Proclaim, Eterna |
| Medtronic, INC. | $2,218.96 | 2022-2023 | Vanta Adaptivestim, Intellis Adaptivestim |
| Stryker Corporation | $1,039.69 | 2023 | Spinejack |
| Abbvie INC. | $350.00 | 2022-2024 | |
| Vertos Medical, INC. | $334.00 | 2022-2024 | Mild Device Kit |
| Boston Scientific Corporation | $312.65 | 2024-2025 | Intracept, General - Pain Management |
| Nevro Corp. | $304.68 | 2023 | Senza |
| Spr Therapeutics, INC | $106.57 | 2023-2025 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $32.06 | 2025 | |
| Cardiva Medical, INC. | $27.10 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Mallinckrodt Hospital Products INC. | $21.74 | 2024 | Terlivaz |
| Collegium Pharmaceutical, INC. | $19.68 | 2024 | Belbuca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Eike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.